Company intelligence / Profile preview

Dalton Medicinal Chemistry Partners

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Dalton Medicinal Chemistry Partners is a joint venture that provides mechanism-based medicinal chemistry services for drug discovery, with a track record of identifying novel chemical entities for three publicly announced partnerships with biotech companies (BioRelix, Bikam) and pharma (Boehringer Ingelheim). The team offers Fragment-to-Lead, Hit-to-Lead, and Lead Optimization capabilities across various target types and therapeutic areas.

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

BioRelixBikamBoehringer Ingelheim

Beyond the preview

Go deeper on Dalton Medicinal Chemistry Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dalton Medicinal Chemistry Partners.

Explore the full profile